Researchers and policymakers must challenge the default framing and stereotypical minority myth mindset which uniformly classifies AANHPI communities as low-risk, hindering both visibility and resource allocation.
The opioid settlement funds provide a crucial opportunity to get increased state or municipal funding behind mail-based naloxone delivery. Through partnering with existing organizations that already have robust infrastructure in place and substantial experience in mail-based naloxone municipalities can scale efforts efficiently.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Even as studies and personal experiences repeatedly reflect the effectiveness of MOUD, a stigma about this approach and the medication persists, complicating efforts to help more people treat their opioid use disorders.
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities.
While the drop in drug overdose deaths is promising, and could potentially be partially attributed to the efforts of the federal government, we must remain cognizant about the sheer number of lives we continue to lose every year to overdose.
Policymakers should recognize the advantages of this multi-faceted care model and ensure legislative and regulatory environments allow for its continued growth.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Dr. Brian Clear, an addiction treatment physician and chief medical officer of Bicycle Health, believes that telemedicine is one way to improve access and reduce the inequities inherence in addiction treatment. The other is education.
While communities should tailor their opioid settlement spending strategies to their local needs, we should embrace basic, population-focused prevention strategies. Prevention efforts can turn the tide of addiction for decades to come. And they are where we’ll get the biggest bang for our buck.
In some ways, the Drug Enforcement Agency’s (DEA) proposed rules for prescribing controlled substances via telemedicine are a sign of progress. Behavioral health could be getting some much-needed clarity, but at what cost?
Patients with opioid use disorder are more likely to stick with their treatment plan when offered buprenorphine via telemedicine, according to a new study. The study involved 1,378 patients, and their 180-day treatment retention rate was 56.4%.
How to turn analytics into actual policy outcomes.
Zack Gray, CEO of digital health startup Ophelia, aims to help “the invisible 80%” of opioid use sufferers in America who are unengaged with the healthcare system until forced to, due to the onset of complications. He believes that states need to reimburse this treatment appropriately.